Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
about
The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimismTargeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in miceTarget delivery and controlled release of the chemopreventive drug sulindac by using an advanced layered double hydroxide nanomatrix formulation system.Polyamines and Gut Mucosal Homeostasis.Green synthesis and biological evaluation of new di-α-aminophosphonate derivatives as cytotoxic agents.Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agentsChemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds.The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo.NSAIDs and Colorectal Cancer Control: Promise and ChallengesTopical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer.Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studiesAerosol administration of phospho-sulindac inhibits lung tumorigenesisCurcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics.The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1.A novel Ras inhibitor (MDC-1016) reduces human pancreatic tumor growth in miceThe proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.Difluoromethylornithine in cancer: new advances.Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat.Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles.CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development.Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression.
P2860
Q28087427-3CA4BF62-C1CC-40D2-B8CE-AC858624A57BQ28487437-FD96673B-168D-4B2E-8DBA-04A6330CE082Q34164842-C6392512-3487-4351-A0AA-D81FFD6FD2ADQ34186523-F7DD6740-9590-497B-8588-45A2F303E6BEQ35038223-4D49DDD1-8BD2-4126-A662-B75B359B72E1Q35188164-9D452A56-6801-4467-9D6B-3635A0171ECBQ35624238-B9B73120-B1DB-4B50-82E7-739C4E8FF36EQ36147300-5E061195-07AA-4EF6-ACB3-BE393258A1FCQ36158947-F8AAB566-F342-4720-A847-0097CD9BBBA0Q36381490-FC65E761-B9E0-4259-830C-1F41131351B2Q36642853-486FD651-5423-4BCF-895A-91ECE99ADFC0Q36645178-27098EFE-FA11-4F72-9FA2-50EFF6FAC43DQ36740696-F2A0778F-6607-41DA-8361-7E61BD052D31Q37191096-B4D3EE80-26CD-475D-9BAC-83551B1C8FDEQ37209494-64D4FFBF-3CBB-426A-8CFF-CD93A6531985Q37220522-AFB2FAFD-785C-4B08-B75A-28B31909DC22Q37285560-2C884133-7758-40C3-AA72-92608CE76045Q38132159-B2AFDED6-4B48-448E-959F-52A5A5490F7AQ38765477-60AED999-0614-4F97-B132-100177B19BF9Q39212655-D83D5450-2190-4C18-9E0F-0DA78975894DQ41390442-A253FDC6-4E35-4838-9090-E8F2D04B7ED8Q43297335-81E5EA0B-BAC8-4C3D-AB78-45348A02C699Q55076084-9FEB4C48-38D8-47A1-B534-F8D0B945920C
P2860
Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phospho-sulindac (OXT-328) com ...... prevents colon cancer in mice.
@ast
Phospho-sulindac (OXT-328) com ...... prevents colon cancer in mice.
@en
type
label
Phospho-sulindac (OXT-328) com ...... prevents colon cancer in mice.
@ast
Phospho-sulindac (OXT-328) com ...... prevents colon cancer in mice.
@en
prefLabel
Phospho-sulindac (OXT-328) com ...... prevents colon cancer in mice.
@ast
Phospho-sulindac (OXT-328) com ...... prevents colon cancer in mice.
@en
P2093
P2860
P1476
Phospho-sulindac (OXT-328) com ...... prevents colon cancer in mice.
@en
P2093
Basil Rigas
Despina Komninou
Gerardo G Mackenzie
Kvetoslava Vrankova
Levy Kopelovich
Liqun Huang
Nengtai Ouyang
P2860
P304
P356
10.1158/1940-6207.CAPR-11-0067
P577
2011-04-04T00:00:00Z